Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDM44
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $988,986
Award facts
- Contract value 100% obligated
- $988,986.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $988,986 by the Defense Logistics Agency on September 29, 2025. The delivery order, which falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, calls for the supply of 300 mg vials of Entyvio, a pharmaceutical product for distribution to Department of Defense healthcare facilities. The contract utilizes no set-aside designation and carries an ultimate completion date of October 21, 2025, with performance taking place at the contractor's Park Ridge, Illinois location.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical supply chain, particularly for the Defense Logistics Agency's medical procurement needs. The company's broader IDC portfolio encompasses an extensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables serving military healthcare facilities nationwide. The firm fixed-price structure and lack of set-aside designation reflect the contractor's competitive positioning in federal procurement markets, leveraging its woman-owned small business status to secure contracts across a diverse pharmaceutical product portfolio.
Quick answers
Who was awarded contract SPE2DB25FDM44?
SPE2DB25FDM44 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM44 worth?
The government has obligated $988,986 on SPE2DB25FDM44.
Is contract SPE2DB25FDM44 an order under another contract?
Yes. SPE2DB25FDM44 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM44 competed?
The extent of competition for SPE2DB25FDM44 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award